Logo image of FLGT

FULGENT GENETICS INC (FLGT) Stock Analyst Ratings

NASDAQ:FLGT - Nasdaq - US3596641098 - Common Stock - Currency: USD

20.1  +0.19 (+0.95%)

After market: 20.1 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to FLGT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 23.12. This target is 15.03% above the current price.
FLGT was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about FLGT.
In the previous month the buy percentage consensus was at a similar level.
FLGT was analyzed by 9 analysts. More opinions would make the average more meaningful.
FLGT Historical Analyst RatingsFLGT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 20.1020.2023.4623.1226.25 - 0.50% 16.72% 15.03% 30.60%
FLGT Current Analyst RatingFLGT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-05-06 Piper Sandler Maintains Neutral -> Neutral
2025-05-05 Raymond James Reiterate Outperform -> Outperform
2025-03-04 Piper Sandler Maintains Neutral -> Neutral
2024-11-11 Piper Sandler Maintains Neutral -> Neutral
2024-03-06 Piper Sandler Maintains Neutral -> Neutral
2023-12-07 UBS Initiate Neutral
2023-10-16 Piper Sandler Maintains Neutral -> Neutral
2023-03-02 Credit Suisse Maintains Outperform
2022-12-08 Piper Sandler Downgrade Overweight -> Neutral
2022-11-18 Raymond James Initiate Outperform
2022-11-14 Credit Suisse Maintains Outperform
2022-11-14 Piper Sandler Maintains Overweight
2022-08-25 Credit Suisse Initiate Outperform
2022-05-16 Piper Sandler Maintains Overweight
2022-01-25 Oppenheimer Maintains Outperform
2021-08-10 Credit Suisse Maintains Underperform
2021-03-05 Piper Sandler Maintains Overweight